Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Melinda Si Yun, Tan"'
Autor:
Shin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, Yunxin Chen, Yan Chin Tan, Melinda Si Yun Tan, Lawrence Cheng Kiat Ng, Yuh Shan Lee, Colin Phipps, Yeow Tee Goh, Kar Ying Yong, Xin Liu, Wee Joo Chng, Soon Thye Lim, Chandramouli Nagarajan
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-6 (2021)
Abstract The role of central nervous system (CNS) prophylaxis with high-dose methotrexate (HDMTX) in DLBCL is controversial. In this retrospective study, we evaluated the efficacy of prophylactic HDMTX on isolated CNS relapse, concomitant CNS and sys
Externí odkaz:
https://doaj.org/article/72111e925a8f4aaaac16a5c1f9fdd602
Autor:
Chia Jie Tan, Melinda Si Yun Tan, Nagarajan, Chandramouli, Wee Joo Chng, Yen-Lin Chee, Ooi, Melissa, Cheng Kiat Ng, Lawrence, Yunxin Chen, Su Yin Yoong, Joanne, Xin Yi Wong, Wei-Ying Jen
Publikováno v:
JCO Oncology Practice; Dec2023, Vol. 19 Issue 12, p1168-1178, 12p
Autor:
Shin Yeu Ong, Yunxin Chen, Melinda Si Yun Tan, Aloysius Yew Leng Ho, William Ying Khee Hwang, Francesca Lorraine Wei Inng Lim
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92addec85bcb2f0e9e1135437dfa8227
https://doi.org/10.1111/ejh.13964
https://doi.org/10.1111/ejh.13964
Autor:
Hui Zhuan Tan, Chandramouli Nagarajan, Melinda Si Yun Tan, Cynthia Lim, Riece Koniman, Jason Choo
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS We aimed to evaluate the incidence and clinical features of patients with biopsy-proven dysproteinemic kidney diseases (group 1), as well as spectrum of biopsy-proven kidney diseases of patients with monoclonal gammopathy (MG) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9e5a5c3297d611fdb23e55ece850a35
https://doi.org/10.1093/ndt/gfac066.017
https://doi.org/10.1093/ndt/gfac066.017
Autor:
Riece, Koniman, Su Hooi, Teo, Manish, Kaushik, Chandramouli, Nagarajan, Melinda Si Yun, Tan, Han Khim, Tan, Maria Erika Gapas, Ramirez, Cynthia Ciwei, Lim
Publikováno v:
Seminars in dialysisREFERENCES.
Patients with multiple myeloma and high serum levels of circulating free light chains (FLC) have increased risk of acute kidney injury (AKI) secondary to cast nephropathy and is associated with poor survival. Despite removal of FLC by medium cutoff (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3a2f4fdadef19525a458e9ac7951b1
https://pubmed.ncbi.nlm.nih.gov/35840146
https://pubmed.ncbi.nlm.nih.gov/35840146
Autor:
Truls Østbye, Sandra Lynn Jaya-Bodestyne, Rahul Malhotra, Melinda Si Yun Tan, John J.B. Allen, Lai Heng Lee, Sophie Seine Xuan Tan, Yang Yong, Thiam Chye Tan, Lay Kok Tan, Kok Hian Tan, Lawrence Cheng Kiat Ng
Publikováno v:
Journal of Perinatal Medicine. 49:153-158
Objectives Pregnancy-associated venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is associated with increased risk of maternal mortality and morbidity. This study aimed to assess potential risk factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::941e4300ed2c8e76cb246f966bc7fc13
https://doi.org/10.1515/jpm-2020-0298
https://doi.org/10.1515/jpm-2020-0298
Publikováno v:
Patient Preference and Adherence. 14:301-308
Introduction The number of treatment options for myeloma and indolent lymphoma are expanding at an exponential rate, with few direct head-to-head comparisons on which to base efficacy measures. We sought to understand how patients, their caregivers a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58428c022598fab5396ecdf37e18c0ac
https://doi.org/10.2147/ppa.s241340
https://doi.org/10.2147/ppa.s241340
Autor:
Jing Yuan Tan, Shin Yeu Ong, Sanjay de Mel, Allan Goh, Atiqa Rahmat, Yang Song, null Jayalakshmi, Melinda Si Yun Tan, Lawrence Cheng Kiat Ng, Yunxin Chen, Francesca Wei Inng Lim, Yeow Tee Goh, Nicholas Francis Grigoropoulos, Michelle Poon, Chandramouli Nagarajan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S126-S127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::988d7029364e03a47894626e5dd371ca
https://doi.org/10.1016/s2152-2650(22)00497-9
https://doi.org/10.1016/s2152-2650(22)00497-9
Publikováno v:
Patient preference and adherence
Introduction The number of treatment options for myeloma and indolent lymphoma are expanding at an exponential rate, with few direct head-to-head comparisons on which to base efficacy measures. We sought to understand how patients, their caregivers a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c53bf69f99146b5030b4f6da3f3ef421
https://pubmed.ncbi.nlm.nih.gov/32109996
https://pubmed.ncbi.nlm.nih.gov/32109996
Autor:
Sathish Kumar Gopalakrishnan, Jane L Chua, Yuh Shan Lee, Lawrence Ng, Colin Phipps, Yunxin Chen, Yeow Tee Goh, Chandramouli Nagarajan, Heng Joo Ng, William Yk Hwang, Melinda Si Yun Tan, Nicholas Francis Grigoropoulos, Shin Yeu Ong
Publikováno v:
Blood. 136:25-26
Introduction Patients with relapsed/ refractory (R/R) diffuse large B-cell lymphoma (DLBCL) whom are transplant-ineligible have limited treatment options. To address this specific treatment challenge, we undertook a clinical trial combining lenalidom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b70ec3e4ad3ed563cdf46889da5b7299
https://doi.org/10.1182/blood-2020-142275
https://doi.org/10.1182/blood-2020-142275